Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis

INTRODUCTION: New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, prompting wide debate about fair and affordable prices. This study systematically compared the price and affordability of sofosbuvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyengar, Swathi, Tay-Teo, Kiu, Vogler, Sabine, Beyer, Peter, Wiktor, Stefan, de Joncheere, Kees, Hill, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886962/
https://www.ncbi.nlm.nih.gov/pubmed/27243629
http://dx.doi.org/10.1371/journal.pmed.1002032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886962/
https://www.ncbi.nlm.nih.gov/pubmed/27243629
http://dx.doi.org/10.1371/journal.pmed.1002032

Ejemplares similares